Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX
This essay examines the extent to which COVID-19 Vaccines Global Access (COVAX) has been a successful mechanism for global COVID-19 vaccine equity as a component of the human right to health. First, I provide background on COVID-19 vaccine equity and COVAX as part of the Access to COVID-19 Tools ACT...
Saved in:
Main Author: | Kaitlin Fajber (Author) |
---|---|
Format: | Book |
Published: |
Harvard FXB Center for Health and Human Rights,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risky business: COVAX and the financialization of global vaccine equity
by: Felix Stein
Published: (2021) -
Global health research, partnership, and equity: no more business-as-usual
by: Zarowsky Christina
Published: (2011) -
COVAX, vaccine donations and the politics of global vaccine inequity
by: Antoine de Bengy Puyvallée, et al.
Published: (2022) -
Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines
by: Tania Manriquez Roa, et al.
Published: (2021) -
The Business, As Usual
by: Sharkey, Jack, 1931-1992